Find your next paid study

LTZ Therapeutics, Inc.NCT07878988

~$150 – $4,200

Actual pay is set by the research site.

Phase IIImetelstatMyelodysplastic (MDS) / Myeloproliferative (MPN) Diseases

Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative Neoplasms

To learn if imetelstat can help to control MDS/MPNs.

M.D. Anderson Cancer CenterNCT07549451

Actual pay is set by the research site.

Phase II Clinical TrialBlinatumomabOlverembatinib+2 more

Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL)

To find out if giving blinatumomab as injections under the skin and olverembatinib can help to control the disease in patients with Ph-positive ALL.

M.D. Anderson Cancer CenterNCT07178912

Actual pay is set by the research site.

Phase 3

A Double-blind, Randomized, Placebo-controlled, Parallel-controlled, Multi-center Phase III Clinical Trial to Evaluate the Efficacy and Safety of a Botanical Total Coumarin Cream (TC Cream) in Treating Patients With Psoriasis Vulgaris

The goal of this clinical trial is to learn if a botanical Total Coumarin topical cream (TC Cream) works to treat psoriasis in adults. It will also learn about…

Psoriasis VulgarisTopical AdministrationPhase III

Psoriasis Research Institute of GuangzhouNCT07426120

~$50 – $2,250

Actual pay is set by the research site.

Phase IISacituzumabTirumotecan+1 more

Phase II Trial of Sacituzumab Tirumotecan in Patients With SMARCB1-Deficient Renal Medullary Carcinoma

To learn if sacituzumab tirumotecan can help to control advanced or metastatic SMARCB1-deficient RMC in patients whose disease has progressed after receiving a…

M.D. Anderson Cancer CenterNCT07438626

Actual pay is set by the research site.

Phase IIIvonescimabIntraperitoneal+3 more

A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA)

To evaluate the safety and effectiveness of Ivonescimab combined with intraperitoneal paclitaxel (IP PTX) in patients with unresectable metastatic high-grade A…

M.D. Anderson Cancer CenterNCT07753824

Actual pay is set by the research site.

Phase 1

Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer

To find the recommended dose of the combination of avutometinib, defactinib, and everolimus in patients with endometrial cancer that is recurrent and has abnor…

Phase IBAvutometinibRAS Pathway+1 more

M.D. Anderson Cancer CenterNCT07318324

~$150 – $3,000

Actual pay is set by the research site.

Phase 1

Zotatifin And EIF4A Platinum Helix Inhibition In Resistant AdvancedTNBC

To find the optimal (best) recommended dose of zotatifin and carboplatin to treat patients with metastatic or recurrent TNBC.

Phase IBZotatifinEIF4A+2 more

M.D. Anderson Cancer CenterNCT07783659

~$150 – $3,000

Actual pay is set by the research site.

Phase 1

Pilot Study on the Effects of Psilocybin on Belief Updating and Insight Formation

The primary aim of this phase I mechanistic pilot study is to evaluate the effects of psilocybin on aspects of cognition in healthy adult volunteers. Up to 24 …

Phase I